marketcaparena
Search

    NEO

    NEOGENOMICS INC

    Company overview

    Market capitalization
    $2.48B
    Employees
    2,500
    Latest publication
    2026-09-29
    About NEOGENOMICS INC

    NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20202020-12-31 · USDQ3 20202020-09-30 · USDQ4 20192019-12-31 · USDQ3 20192019-09-30 · USDQ2 20192019-06-30 · USDQ1 20192019-03-31 · USDQ4 20182018-12-31 · USD
    Total Revenue201,656,000USD125,997,000USD125,444,000USD106,868,000USD104,672,000USD101,713,000USD95,577,000USD76,475,000USD
    Cost Of Revenue109,778,000USD68,544,000USD71,379,000USD56,945,000USD53,840,000USD52,747,000USD48,462,000USD39,364,000USD
    Gross Profit91,878,000USD57,453,000USD54,065,000USD49,923,000USD50,832,000USD48,966,000USD44,556,000USD37,111,000USD
    Research Development10,761,000USD2,100,000USD1,964,000USD2,080,000USD2,611,000USD2,587,000USD1,209,000USD526,000USD
    Selling And Marketing Expenses27,275,000USD13,105,000USD11,304,000USD12,302,000USD11,508,000USD12,324,000USD11,216,000USD8,047,000USD
    General And Administrative Expenses63,613,000USD———————
    Total Operating Expenses101,649,000USD51,914,000USD49,396,000USD47,602,000USD47,173,000USD44,488,000USD44,567,000USD34,290,000USD
    Operating Income-9,771,000USD5,539,000USD4,669,000USD2,321,000USD3,659,000USD4,478,000USD2,548,000USD2,821,000USD
    Total Other Income Expense Net11,597,000USD2,028,000USD-2,447,000USD114,000USD-168,000USD-2,312,000USD-6,995,000USD-1,419,000USD
    Interest Income1,214,000USD——380,000USD203,000USD1,304,000USD1,826,000USD—
    Interest Expense781,000USD2,194,000USD2,458,000USD380,000USD203,000USD1,304,000USD1,826,000USD1,464,000USD
    Income Before Tax1,826,000USD7,567,000USD2,222,000USD2,435,000USD3,491,000USD2,166,000USD-4,447,000USD1,403,000USD
    Income Tax Expense-412,000USD-7,850,000USD-335,000USD-3,861,000USD1,348,000USD175,000USD-2,023,000USD1,050,000USD
    Net Income2,238,000USD15,417,000USD2,557,000USD6,296,000USD2,143,000USD1,991,000USD-2,424,000USD353,000USD
    Selling General Administrative—36,709,000USD36,128,000USD33,220,000USD33,054,000USD29,577,000USD32,142,000USD25,717,000USD
    Net Interest Income—-2,194,000USD-2,458,000USD-380,000USD-203,000USD-1,304,000USD-1,826,000USD—
    Tax Provision—-7,850,000USD-335,000USD-3,861,000USD1,348,000USD175,000USD-2,023,000USD—
    Net Income From Continuing Ops—15,417,000USD2,557,000USD6,296,000USD2,143,000USD1,991,000USD-2,424,000USD353,000USD
    Ebit—9,761,000USD4,669,000USD2,815,000USD3,694,000USD3,470,000USD-2,621,000USD2,821,000USD
    Ebitda—19,390,000USD13,665,000USD10,404,000USD10,922,000USD11,094,000USD5,209,000USD8,821,000USD
    Depreciation And Amortization—9,629,000USD8,996,000USD7,589,000USD7,228,000USD7,624,000USD7,830,000USD6,000,000USD
    Reconciled Depreciation—9,629,000USD8,996,000USD7,589,000USD7,228,000USD7,624,000USD7,830,000USD6,000,000USD
    Non Operating Income Net Other—4,222,000USD11,000USD494,000USD35,000USD-1,008,000USD-5,169,000USD45,000USD
    Net Income Applicable To Common Shares—15,417,000USD2,557,000USD6,296,000USD2,143,000USD1,991,000USD-2,424,000USD353,000USD
    Minority Interest———————0USD
    Discontinued Operations———————0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20142014-12-31 · USDFY 20132013-12-31 · USDFY 20112011-12-31 · USDFY 20082008-12-31 · USD
    Total Revenue408,830,000USD276,741,000USD240,251,000USD244,083,000USD87,069,000USD66,467,000USD43,484,000USD20,015,000USD
    Cost Of Revenue211,994,000USD149,476,000USD138,295,000USD133,704,000USD46,355,000USD34,730,000USD24,056,000USD9,354,000USD
    Gross Profit196,836,000USD127,265,000USD101,956,000USD110,379,000USD40,714,000USD31,737,000USD19,428,000USD10,661,000USD
    Research Development8,487,000USD3,001,000USD3,636,000USD4,649,000USD2,689,000USD2,440,000USD543,000USD—
    Selling General Administrative127,993,000USD84,822,000USD88,755,000USD63,926,000USD23,808,000USD17,397,000USD12,874,000USD11,545,456USD
    Selling And Marketing Expenses47,350,000USD29,402,000USD—23,910,000USD11,999,000USD8,726,000USD6,963,000USD—
    Total Operating Expenses183,830,000USD117,225,000USD99,054,000USD95,949,000USD38,496,000USD28,563,000USD19,837,000USD11,545,000USD
    Operating Income13,006,000USD10,040,000USD2,902,000USD2,574,000USD2,218,000USD3,174,000USD-409,000USD-884,000USD
    Interest Income3,713,000USD6,230,000USD5,540,000USD9,998,000USD————
    Interest Expense3,713,000USD6,230,000USD5,540,000USD9,998,000USD929,000USD989,000USD768,000USD308,523USD
    Net Interest Income-3,713,000USD-6,230,000USD-5,540,000USD-9,998,000USD————
    Income Before Tax3,645,000USD3,824,000USD-2,650,000USD-7,424,000USD1,289,000USD2,185,000USD-2,700USD-1,074,000USD
    Income Tax Expense-4,361,000USD1,184,000USD-2,254,000USD-1,701,000USD157,000USD152,000USD768,000USD180,148USD
    Tax Provision-4,361,000USD1,184,000USD-2,635,000USD-1,701,000USD————
    Net Income8,006,000USD2,640,000USD-396,000USD-6,142,000USD1,132,000USD2,033,000USD-1,177,000USD-1,383,000USD
    Net Income From Continuing Ops8,006,000USD2,640,000USD-846,000USD-5,723,000USD1,132,000USD2,033,000USD-1,177,000USD—
    Ebit7,358,000USD10,054,000USD3,960,000USD2,155,000USD2,218,000USD3,174,000USD-409,000USD-883,564USD
    Ebitda37,629,000USD31,786,000USD26,551,000USD25,364,000USD7,858,000USD7,586,000USD1,676,000USD-143,000USD
    Depreciation And Amortization30,271,000USD21,732,000USD22,591,000USD23,209,000USD5,640,000USD4,412,000USD2,085,000USD740,564USD
    Reconciled Depreciation30,271,000USD21,732,000USD22,591,000USD—————
    Total Other Income Expense Net-9,361,000USD-6,216,000USD-5,552,000USD-9,998,000USD-929,000USD-989,000USD-768,000USD-499,000USD
    Non Operating Income Net Other-5,648,000USD14,000USD-265,000USD—-929,000USD———
    Net Income Applicable To Common Shares8,006,000USD6,088,000USD-11,393,000USD-30,397,000USD1,132,000USD2,033,000USD-1,177,000USD—
    Unclassified Operating Expenses——6,663,000USD3,464,000USD————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,352,243,000USD1,346,531,000USD1,359,830,000USD1,374,780,000USD1,393,950,000USD1,601,430,000USD1,638,038,000USD1,641,111,000USD
    Cash And Equivalents145,539,000USD———————
    Total Current Assets381,478,000USD373,684,000USD376,286,000USD382,286,000USD392,354,000USD573,932,000USD596,019,000USD590,241,000USD
    Other Current Assets9,807,000USD30,280,000USD28,860,000USD33,913,000USD40,873,000USD34,872,000USD31,887,000USD26,543,000USD
    Other Non Current Assets9,311,000USD———————
    Total Liabilities566,511,000USD———————
    Total Current Liabilities105,883,000USD84,590,000USD88,300,000USD97,866,000USD100,120,000USD279,695,000USD301,241,000USD296,406,000USD
    Other Non Current Liabilities862,000USD———————
    Total Stockholder Equity785,732,000USD828,760,000USD836,562,000USD838,290,000USD854,040,000USD888,269,000USD902,339,000USD908,210,000USD
    Total Equity Including Noncontrolling Interest785,732,000USD———————
    Deferred Revenue194,000USD———————
    Net Receivables175,405,000USD167,424,000USD159,242,000USD155,796,000USD153,625,000USD151,208,000USD150,540,000USD151,428,000USD
    Inventory27,137,000USD29,837,000USD28,566,000USD28,460,000USD34,171,000USD29,772,000USD26,748,000USD24,457,000USD
    Property Plant Equipment Net159,544,000USD160,362,000USD163,278,000USD165,620,000USD168,332,000USD167,406,000USD173,686,000USD174,480,000USD
    Goodwill523,995,000USD———————
    Intangible Assets271,262,000USD278,895,000USD286,528,000USD294,162,000USD301,795,000USD331,319,000USD339,681,000USD348,042,000USD
    Accounts Payable20,953,000USD25,898,000USD23,090,000USD22,611,000USD27,492,000USD16,211,000USD21,607,000USD16,514,000USD
    Short Term Debt3,722,000USD4,828,000USD4,776,000USD4,507,000USD4,051,999USD204,206,000USD204,158,000USD204,140,000USD
    Retained Earnings-448,674,000USD-450,912,000USD-433,806,000USD-423,925,000USD-396,796,000USD-351,704,000USD-325,781,000USD-310,457,000USD
    Accumulated Other Comprehensive Income4,000USD4,000USD4,000USD71,000USD29,000USD-56,000USD-206,000USD-643,000USD
    Total Liab—517,771,000USD523,268,000USD536,490,000USD539,910,000USD713,161,000USD735,699,000USD732,901,000USD
    Other Current Liab—53,303,000USD60,434,000USD69,172,000USD67,492,000USD58,115,000USD75,067,000USD75,163,000USD
    Common Stock—129,000USD129,000USD128,000USD128,000USD128,000USD128,000USD128,000USD
    Capital Stock—129,000USD129,000USD128,000USD128,000USD128,000USD128,000USD128,000USD
    Good Will—523,995,000USD524,344,000USD524,344,000USD524,143,000USD522,766,000USD522,766,000USD522,766,000USD
    Cash—146,143,000USD159,618,000USD164,117,000USD154,723,000USD346,194,000USD367,012,000USD361,992,000USD
    Cash And Short Term Investments—146,143,000USD159,618,000USD164,117,000USD163,685,000USD358,080,000USD386,844,000USD387,813,000USD
    Current Deferred Revenue—561,000USD—1,576,000USD1,084,000USD1,163,000USD409,000USD589,000USD
    Net Debt—262,386,000USD312,660,000USD246,191,000USD257,040,000USD258,587,000USD238,322,000USD244,276,000USD
    Short Long Term Debt Total—408,529,000USD472,278,000USD410,308,000USD411,763,000USD604,781,000USD605,334,000USD606,268,000USD
    Long Term Debt—342,240,000USD341,858,000USD341,476,000USD341,095,000USD340,714,000USD340,335,000USD339,956,000USD
    Property Plant Equipment Gross—376,328,000USD372,335,000USD374,597,000USD369,021,000USD366,101,000USD363,676,000USD355,820,000USD
    Common Stock Shares Outstanding—25,833,200shares25,729,600shares25,583,400shares25,589,800shares25,475,200shares25,331,600shares25,390,600shares
    Non Current Assets Total—972,847,000USD983,544,000USD992,493,999USD1,001,596,000USD1,027,498,000USD1,042,019,000USD1,050,870,000USD
    Non Current Liabilities Total—433,181,000USD434,968,000USD438,624,000USD439,789,999USD433,466,000USD434,458,000USD436,495,000USD
    Non Current Liabilities Other—12,030,000USD12,069,000USD11,977,000USD12,103,000USD11,921,000USD11,772,000USD11,596,000USD
    Non Currrent Assets Other—9,595,000USD9,394,000USD8,367,999USD7,326,000USD6,007,000USD5,886,000USD5,582,000USD
    Net Working Capital—289,094,000USD287,986,000USD284,599,000USD292,433,000USD294,237,000USD294,778,000USD293,835,000USD
    Unclassified Non Current Liabilities—78,911,000USD81,041,000USD85,171,000USD86,591,999USD80,831,000USD82,351,000USD84,943,000USD
    Unclassified Equity—1,279,410,000USD1,270,106,000USD1,261,888,000USD1,250,551,000USD1,239,773,000USD1,228,070,000USD1,219,054,000USD
    Short Term Investments——0USD0USD8,962,000USD11,886,000USD19,832,000USD25,821,000USD
    Short Long Term Debt—————201,131,000USD200,777,000USD200,424,000USD
    Unclassified Current Liabilities—————-201,131,000USD-200,777,000USD-200,424,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,359,830,000USD1,638,038,000USD1,681,229,000USD1,740,034,000USD1,869,778,000USD988,331,000USD709,506,000USD505,015,000USD
    Intangible Assets286,528,000USD339,681,000USD373,128,000USD408,260,000USD442,325,000USD120,653,000USD126,640,000USD140,029,000USD
    Other Current Assets28,860,000USD31,887,000USD26,189,000USD23,314,000USD30,593,000USD16,102,000USD8,075,000USD8,288,000USD
    Total Liab523,268,000USD735,699,000USD739,692,000USD742,011,000USD761,501,000USD294,037,000USD202,098,000USD184,572,000USD
    Total Stockholder Equity836,562,000USD902,339,000USD941,537,000USD998,023,000USD1,108,277,000USD694,294,000USD507,408,000USD320,443,000USD
    Other Current Liab60,434,000USD75,067,000USD68,230,000USD55,211,000USD54,965,000USD36,381,000USD28,913,000USD21,750,000USD
    Common Stock129,000USD128,000USD127,000USD127,000USD124,000USD112,000USD105,000USD94,000USD
    Capital Stock129,000USD128,000USD127,000USD127,000USD124,000USD112,000USD105,000USD94,000USD
    Retained Earnings-433,806,000USD-325,781,000USD-247,055,000USD-159,087,000USD-14,837,000USD-7,185,000USD-11,357,000USD-51,258,000USD
    Good Will524,344,000USD522,766,000USD522,766,000USD522,766,000USD527,115,000USD211,083,000USD198,601,000USD197,892,000USD
    Cash159,618,000USD367,012,000USD342,488,000USD263,180,000USD316,827,000USD228,713,000USD173,016,000USD9,811,000USD
    Cash And Short Term Investments159,618,000USD386,844,000USD415,203,000USD437,989,000USD515,390,000USD296,259,000USD173,016,000USD9,811,000USD
    Total Current Assets376,286,000USD596,019,000USD596,812,000USD605,291,000USD681,508,000USD448,730,000USD290,738,000USD103,668,000USD
    Total Current Liabilities88,300,000USD301,241,000USD96,304,000USD89,932,000USD87,232,000USD73,183,000USD63,904,000USD60,925,000USD
    Net Debt312,660,000USD238,322,000USD269,191,000USD347,748,000USD295,964,000USD-10,489,000USD-40,141,000USD102,490,000USD
    Short Term Debt4,776,000USD204,158,000USD5,610,000USD6,654,000USD9,154,000USD7,808,000USD13,813,000USD20,469,000USD
    Short Long Term Debt Total472,278,000USD605,334,000USD611,679,000USD610,928,000USD612,791,000USD218,224,000USD132,875,000USD112,301,000USD
    Long Term Debt341,858,000USD340,335,000USD538,198,000USD535,322,000USD532,483,000USD168,120,000USD91,829,000USD92,880,000USD
    Short Term Investments0USD19,832,000USD72,715,000USD174,809,000USD198,563,000USD67,546,000USD——
    Net Receivables159,242,000USD150,540,000USD131,264,000USD119,711,000USD112,130,000USD106,843,000USD95,242,000USD76,919,000USD
    Inventory28,566,000USD26,748,000USD24,156,000USD24,277,000USD23,395,000USD29,526,000USD14,405,000USD8,650,000USD
    Accounts Payable23,090,000USD21,607,000USD20,334,000USD20,510,000USD17,921,000USD24,965,000USD19,568,000USD17,779,000USD
    Property Plant Equipment Net163,278,000USD173,686,000USD183,781,000USD198,608,000USD211,662,000USD151,888,000USD90,680,000USD60,888,000USD
    Property Plant Equipment Gross372,335,000USD363,676,000USD341,992,000USD330,538,000USD321,614,000USD131,659,000USD90,680,000USD60,888,000USD
    Accumulated Other Comprehensive Income4,000USD-206,000USD-1,674,000USD-3,899,000USD-638,000USD10,000USD-1,618,000USD-579,000USD
    Common Stock Shares Outstanding25,620,200shares25,331,600shares25,100,400shares24,843,400shares23,992,400shares22,358,800shares20,723,000shares18,313,600shares
    Non Current Assets Total983,544,000USD1,042,019,000USD1,084,417,000USD1,134,743,000USD1,188,270,000USD539,601,000USD418,768,000USD401,347,000USD
    Non Current Liabilities Total434,968,000USD434,458,000USD643,388,000USD652,079,000USD674,269,000USD220,854,000USD138,194,000USD123,647,000USD
    Non Current Liabilities Other12,069,000USD11,772,000USD13,034,000USD13,055,000USD14,022,000USD47,319,000USD6,765,000USD3,060,000USD
    Non Currrent Assets Other9,394,000USD5,886,000USD4,742,000USD-29,672,000USD-48,543,000USD21,007,000USD2,694,000USD2,538,000USD
    Net Working Capital287,986,000USD294,778,000USD500,508,000USD515,359,000USD594,276,000USD375,547,000USD226,834,000USD42,743,000USD
    Unclassified Non Current Liabilities81,041,000USD82,351,000USD92,156,000USD21,147,000USD—-10,438,000USD6,902,000USD-19,367,000USD
    Unclassified Equity1,270,106,000USD1,228,070,000USD1,190,012,000USD1,160,755,000USD1,123,504,000USD701,245,000USD520,173,000USD372,092,000USD
    Current Deferred Revenue—409,000USD2,130,000USD7,557,000USD5,192,000USD4,029,000USD1,610,000USD927,000USD
    Short Long Term Debt—200,777,000USD————5,000,000USD7,873,000USD
    Unclassified Current Liabilities—-200,777,000USD————-5,000,000USD-7,873,000USD
    Deferred Long Term Liab———34,750,000USD55,475,000USD5,415,000USD15,566,000USD22,457,000USD
    Other Liab———47,805,000USD69,497,000USD10,438,000USD17,132,000USD24,617,000USD
    Other Assets———5,109,000USD7,168,000USD54,446,000USD2,847,000USD2,038,000USD
    Net Tangible Assets———66,997,000USD138,837,000USD362,558,000USD182,167,000USD-17,478,000USD
    Long Term Investments————0USD29,555,000USD0USD500,000USD
    Unclassified Non Current Assets—————-49,031,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-17,106,000USD-9,881,000USD-27,129,000USD-45,092,000USD-25,923,000USD-15,324,000USD-17,699,000USD-18,642,000USD
    Depreciation16,413,000USD16,395,000USD16,437,000USD17,264,000USD17,728,000USD18,188,000USD17,985,000USD18,107,000USD
    Stock Based Compensation9,636,000USD8,042,000USD10,306,000USD12,214,000USD10,754,000USD8,328,000USD8,470,000USD8,841,000USD
    Other Non Cash Items2,122,000USD10,469,000USD9,496,000USD21,931,000USD2,356,000USD2,678,000USD2,209,000USD3,523,000USD
    Change To Account Receivables-8,182,000USD-4,207,000USD-2,368,000USD1,065,000USD-668,000USD888,000USD-4,848,000USD-6,301,000USD
    Change To Inventory-1,271,000USD-28,000USD5,632,000USD-4,123,000USD-3,024,000USD-2,291,000USD-1,243,000USD-3,001,000USD
    Change In Working Capital-19,202,000USD-15,640,000USD-226,000USD14,013,000USD-30,242,000USD-4,070,000USD-2,514,000USD2,063,000USD
    Total Cash From Operating Activities-8,137,000USD1,343,000USD8,884,000USD20,330,000USD-25,327,000USD9,800,000USD9,246,000USD13,892,000USD
    Capital Expenditures-5,000,000USD-7,871,000USD-8,314,000USD-6,323,000USD-4,500,000USD-11,599,000USD-10,799,000USD-13,078,000USD
    Free Cash Flow-13,137,000USD-6,528,000USD570,000USD14,007,000USD-29,827,000USD-1,799,000USD-1,553,000USD814,000USD
    Investments0USD0USD-277,000USD-9,314,000USD3,560,000USD-5,467,000USD-3,516,000USD7,313,000USD
    Total Cashflows From Investing Activities-5,000,000USD-6,305,000USD-277,000USD-9,314,000USD3,560,000USD-5,467,000USD-3,516,000USD7,313,000USD
    Total Cash From Financing Activities-338,000USD431,000USD765,000USD-202,433,000USD949,000USD687,000USD1,177,000USD1,966,000USD
    Sale Purchase Of Stock-338,000USD———————
    Change In Cash-13,475,000USD-4,499,000USD9,394,000USD-191,471,000USD-20,818,000USD5,020,000USD6,907,000USD23,171,000USD
    Begin Period Cash Flow159,618,000USD164,117,000USD154,723,000USD346,194,000USD367,012,000USD361,992,000USD355,085,000USD331,914,000USD
    End Period Cash Flow146,143,000USD159,618,000USD164,117,000USD154,723,000USD346,194,000USD367,012,000USD361,992,000USD355,085,000USD
    Other Cashflows From Financing Activities-338,000USD—765,000USD-202,433,000USD949,000USD—-3,516,000USD7,313,000USD
    Net Borrowings—0USD0USD—————
    Issuance Of Capital Stock—431,000USD——949,000USD687,000USD1,177,000USD1,966,000USD
    Other Cashflows From Investing Activities—1,566,000USD-500,000USD————20,391,000USD
    Unclassified Operating Cash Flow—-8,042,000USD——————
    Unclassified Investing Cash Flow——8,814,000USD6,323,000USD4,500,000USD11,599,000USD10,799,000USD-7,313,000USD
    Unclassified Financing Cash Flow——————3,516,000USD-7,313,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-108,025,000USD-78,726,000USD-87,968,000USD-144,250,000USD-8,347,000USD4,172,000USD8,006,000USD2,640,000USD
    Depreciation67,824,000USD72,547,000USD72,583,000USD69,430,000USD53,352,000USD35,721,000USD30,271,000USD21,732,000USD
    Stock Based Compensation41,316,000USD33,413,000USD24,633,000USD24,672,000USD22,458,000USD10,212,000USD10,000,000USD6,955,000USD
    Other Non Cash Items36,210,000USD12,419,000USD14,292,000USD31,954,000USD-89,586,000USD12,151,000USD6,025,000USD542,000USD
    Change To Account Receivables-6,178,000USD-19,313,000USD-11,516,000USD-7,581,000USD-4,691,000USD-12,601,000USD-17,301,000USD209,000USD
    Change To Inventory-1,543,000USD-2,699,000USD-454,000USD-1,100,000USD1,634,000USD-15,197,000USD-5,754,000USD734,000USD
    Change In Working Capital-32,095,000USD-32,630,000USD-25,493,000USD-31,701,000USD-4,600,000USD-61,747,000USD-32,423,000USD12,513,000USD
    Total Cash From Operating Activities5,230,000USD7,023,000USD-1,953,000USD-65,993,000USD-26,723,000USD1,460,000USD23,369,000USD44,786,000USD
    Capital Expenditures-27,008,000USD-41,061,000USD-28,752,000USD-30,891,000USD-64,142,000USD-29,096,000USD-20,029,000USD-14,310,000USD
    Free Cash Flow-21,778,000USD-34,038,000USD-30,705,000USD-96,884,000USD-90,865,000USD-27,636,000USD3,340,000USD30,476,000USD
    Investments19,560,000USD12,855,000USD76,707,000USD517,000USD-133,821,000USD-93,345,000USD-19,630,000USD-139,687,000USD
    Total Cashflows From Investing Activities-12,336,000USD12,855,000USD76,707,000USD517,000USD-632,367,000USD-159,441,000USD-19,630,000USD-139,687,000USD
    Net Borrowings-201,250,000USD0USD0USD-758,000USD331,363,000USD96,926,000USD-5,309,000USD-2,039,000USD
    Total Cash From Financing Activities-200,288,000USD4,646,000USD4,554,000USD11,829,000USD725,285,000USD235,597,000USD159,466,000USD91,959,000USD
    Issuance Of Capital Stock962,000USD4,646,000USD4,624,000USD12,587,000USD423,213,000USD147,603,000USD171,976,000USD144,094,000USD
    Change In Cash-207,394,000USD24,524,000USD79,308,000USD-53,647,000USD66,195,000USD77,616,000USD163,205,000USD-3,010,000USD
    Begin Period Cash Flow367,012,000USD342,488,000USD263,180,000USD316,827,000USD250,632,000USD173,016,000USD9,811,000USD12,821,000USD
    End Period Cash Flow159,618,000USD367,012,000USD342,488,000USD263,180,000USD316,827,000USD250,632,000USD173,016,000USD9,811,000USD
    Other Cashflows From Investing Activities1,566,000USD——12,098,000USD-15,000,000USD-93,345,000USD399,000USD-125,377,000USD
    Other Cashflows From Financing Activities-200,288,000USD—76,707,000USD-758,000USD-32,338,000USD-3,317,000USD98,941,000USD-57,235,000USD
    Unclassified Investing Cash Flow-6,454,000USD41,061,000USD28,752,000USD18,793,000USD-419,404,000USD56,345,000USD19,630,000USD139,687,000USD
    Unclassified Financing Cash Flow200,288,000USD—-76,777,000USD—411,180,000USD121,678,000USD54,632,000USD210,929,000USD
    Change To Liabilities———-13,303,000USD5,151,000USD-3,970,000USD-9,001,000USD12,922,000USD
    Sale Purchase Of Stock———12,587,000USD15,080,000USD20,310,000USD11,202,000USD-50,096,000USD
    Cash And Cash Equivalents Changes———-53,647,000USD66,195,000USD77,616,000USD163,205,000USD-3,010,000USD
    Unclassified Operating Cash Flow———-16,098,000USD——1,490,000USD—
    Dividends Paid———————-9,600,000USD
    Exchange Rate Changes———————-68,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductClient Direct Billing137,956,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductCommercial Insurance36,273,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductMedicare And Other Governmental27,427,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductSelf Pay Services0USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductClient Direct Billing131,606,000USD0001077183-26-000023
    Q1 2026Quarterly · 2026-03-31ProductCommercial Insurance30,938,000USD0001077183-26-000023
    Q1 2026Quarterly · 2026-03-31ProductMedicare And Other Governmental24,145,000USD0001077183-26-000023
    Q1 2026Quarterly · 2026-03-31ProductSelf Pay Services-17,000USD0001077183-26-000023
    Q4 2025Quarterly · 2025-12-31ProductClient Direct Billing133,361,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductCommercial Insurance31,419,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductMedicare And Other Governmental25,404,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductSelf Pay Services0USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductClient Direct Billing518,844,000USD0001077183-26-000010
    FY 2025Yearly · 2025-12-31ProductCommercial Insurance117,508,000USD0001077183-26-000010
    FY 2025Yearly · 2025-12-31ProductMedicare And Other Governmental90,866,000USD0001077183-26-000010
    FY 2025Yearly · 2025-12-31ProductSelf Pay Services114,000USD0001077183-26-000010
    Q3 2025Quarterly · 2025-09-30ProductClient Direct Billing132,288,000USD0001077183-25-000175
    Q3 2025Quarterly · 2025-09-30ProductCommercial Insurance32,466,000USD0001077183-25-000175
    Q3 2025Quarterly · 2025-09-30ProductMedicare And Other Governmental22,974,000USD0001077183-25-000175
    Q3 2025Quarterly · 2025-09-30ProductSelf Pay Services69,000USD0001077183-25-000175
    Q2 2025Quarterly · 2025-06-30ProductClient Direct Billing131,157,000USD0001077183-25-000154
    Q2 2025Quarterly · 2025-06-30ProductCommercial Insurance28,766,000USD0001077183-25-000154
    Q2 2025Quarterly · 2025-06-30ProductMedicare And Other Governmental21,387,000USD0001077183-25-000154
    Q2 2025Quarterly · 2025-06-30ProductSelf Pay Services20,000USD0001077183-25-000154
    Q1 2025Quarterly · 2025-03-31ProductClient Direct Billing122,038,000USD0001077183-26-000023
    Q1 2025Quarterly · 2025-03-31ProductCommercial Insurance24,857,000USD0001077183-26-000023
    Q1 2025Quarterly · 2025-03-31ProductMedicare And Other Governmental21,101,000USD0001077183-26-000023
    Q1 2025Quarterly · 2025-03-31ProductSelf Pay Services39,000USD0001077183-26-000023
    Q4 2024Quarterly · 2024-12-31ProductClient Direct Billing123,303,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductCommercial Insurance26,729,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductMedicare And Other Governmental21,741,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductSelf Pay Services227,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductClient Direct Billing475,444,000USD0001077183-26-000010
    FY 2024Yearly · 2024-12-31ProductCommercial Insurance99,843,000USD0001077183-26-000010
    FY 2024Yearly · 2024-12-31ProductMedicare And Other Governmental84,598,000USD0001077183-26-000010
    FY 2024Yearly · 2024-12-31ProductSelf Pay Services681,000USD0001077183-26-000010
    Q3 2024Quarterly · 2024-09-30ProductClient Direct Billing121,648,000USD0001077183-25-000175
    Q3 2024Quarterly · 2024-09-30ProductCommercial Insurance24,667,000USD0001077183-25-000175
    Q3 2024Quarterly · 2024-09-30ProductMedicare And Other Governmental21,291,000USD0001077183-25-000175
    Q3 2024Quarterly · 2024-09-30ProductSelf Pay Services218,000USD0001077183-25-000175
    Q3 2024Quarterly · 2024-09-30SegmentAdvanced Diagnostics22,041,000USD0001077183-24-000157
    Q3 2024Quarterly · 2024-09-30SegmentClinical Services145,783,000USD0001077183-24-000157
    Q2 2024Quarterly · 2024-06-30SegmentAdvanced Diagnostics23,114,000USD0001077183-24-000109
    Q2 2024Quarterly · 2024-06-30SegmentClinical Services141,388,000USD0001077183-24-000109
    FY 2023Yearly · 2023-12-31ProductClient Direct Billing428,901,000USD0001077183-26-000010
    FY 2023Yearly · 2023-12-31ProductCommercial Insurance88,022,000USD0001077183-26-000010
    FY 2023Yearly · 2023-12-31ProductMedicare And Other Governmental74,370,000USD0001077183-26-000010
    FY 2023Yearly · 2023-12-31ProductSelf Pay Services350,000USD0001077183-26-000010
    FY 2023Yearly · 2023-12-31SegmentAdvanced Diagnostics96,007,000USD0001077183-24-000011
    FY 2023Yearly · 2023-12-31SegmentClinical Services495,636,000USD0001077183-24-000011
    Q3 2023Quarterly · 2023-09-30SegmentAdvanced Diagnostics24,401,000USD0001077183-24-000157
    Q3 2023Quarterly · 2023-09-30SegmentClinical Services127,553,000USD0001077183-24-000157
    Q2 2023Quarterly · 2023-06-30SegmentAdvanced Diagnostics23,761,000USD0001077183-24-000109
    Q2 2023Quarterly · 2023-06-30SegmentClinical Services123,156,000USD0001077183-24-000109
    Q1 2023Quarterly · 2023-03-31SegmentClinical Services114,869,000USD0001077183-23-000042
    Q1 2023Quarterly · 2023-03-31SegmentPharma Services22,351,000USD0001077183-23-000042
    FY 2022Yearly · 2022-12-31ProductClient Direct Billing370,706,000USD0001077183-25-000028
    FY 2022Yearly · 2022-12-31ProductCommercial Insurance73,280,000USD0001077183-25-000028
    FY 2022Yearly · 2022-12-31ProductMedicare And Other Governmental65,585,000USD0001077183-25-000028
    FY 2022Yearly · 2022-12-31ProductSelf Pay Services157,000USD0001077183-25-000028
    FY 2022Yearly · 2022-12-31SegmentAdvanced Diagnostics90,974,000USD0001077183-24-000011
    FY 2022Yearly · 2022-12-31SegmentClinical Services418,754,000USD0001077183-24-000011
    Q3 2022Quarterly · 2022-09-30SegmentAdvanced Diagnostics22,620,000USD0001077183-23-000138
    Q3 2022Quarterly · 2022-09-30SegmentClinical Services106,162,000USD0001077183-23-000138
    Q2 2022Quarterly · 2022-06-30SegmentAdvanced Diagnostics19,437,000USD0001077183-23-000103
    Q2 2022Quarterly · 2022-06-30SegmentClinical Services105,635,000USD0001077183-23-000103
    Q1 2022Quarterly · 2022-03-31SegmentClinical Services98,791,000USD0001077183-23-000042
    Q1 2022Quarterly · 2022-03-31SegmentPharma Services18,378,000USD0001077183-23-000042
    FY 2021Yearly · 2021-12-31SegmentAdvanced Diagnostics80,157,000USD0001077183-24-000011
    FY 2021Yearly · 2021-12-31SegmentClinical Services404,172,000USD0001077183-24-000011

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.